TG Therapeutics | Vermögenswerte



Assets Veränderung Datum
AbbVie USD 135.16B 8.26B 2024-12
Alaunos Therapeutics USD 2.76M 795K 2024-12
Amgen USD 89.37B 2.47B 2025-03
Ardelyx USD 435.75M 67.89M 2024-12
Arrowhead Research USD 1.01B 126.11M 2024-12
Bayer EUR 110.85B 3.9B 2024-12
Biogen USD 28.03B 16.2M 2025-03
Corcept Therapeutics USD 840.55M 56.3M 2024-12
Dynavax Technologies USD 986.26M 75.73M 2024-12
Gilead Sciences USD 56.43B 2.56B 2025-03
J&J USD 193.67B 13.57B 2025-03
Novartis USD 102.25B 1.28B 2024-12
PTC Therapeutics USD 1.71B 137.21M 2024-12
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Roche Holding CHF 101.8B 6.02B 2024-12
TG Therapeutics USD 577.69M 8.32M 2024-12
Vertex Pharmaceuticals USD 22.53B 293M 2024-12



TG Therapeutics Vermögenswerte - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.